ATE273995T1 - Spezifische inhibitoren der pankreatischen lipase und deren anwendungen - Google Patents

Spezifische inhibitoren der pankreatischen lipase und deren anwendungen

Info

Publication number
ATE273995T1
ATE273995T1 AT98902026T AT98902026T ATE273995T1 AT E273995 T1 ATE273995 T1 AT E273995T1 AT 98902026 T AT98902026 T AT 98902026T AT 98902026 T AT98902026 T AT 98902026T AT E273995 T1 ATE273995 T1 AT E273995T1
Authority
AT
Austria
Prior art keywords
pancreatic lipase
applications
lipase inhibitors
specific pancreatic
inhibitors
Prior art date
Application number
AT98902026T
Other languages
English (en)
Inventor
Catherine Chapus
Original Assignee
Lipogel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipogel filed Critical Lipogel
Application granted granted Critical
Publication of ATE273995T1 publication Critical patent/ATE273995T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT98902026T 1997-01-07 1998-01-06 Spezifische inhibitoren der pankreatischen lipase und deren anwendungen ATE273995T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9700071A FR2758143B1 (fr) 1997-01-07 1997-01-07 Inhibiteurs specifiques de la lipase pancreatique et leurs applications
PCT/FR1998/000009 WO1998030588A1 (fr) 1997-01-07 1998-01-06 Inhibiteurs specifiques de la lipase pancreatique et leurs applications

Publications (1)

Publication Number Publication Date
ATE273995T1 true ATE273995T1 (de) 2004-09-15

Family

ID=9502405

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98902026T ATE273995T1 (de) 1997-01-07 1998-01-06 Spezifische inhibitoren der pankreatischen lipase und deren anwendungen

Country Status (14)

Country Link
US (1) US6432400B1 (de)
EP (1) EP0970118B1 (de)
CN (1) CN1248264A (de)
AT (1) ATE273995T1 (de)
AU (1) AU727469B2 (de)
BR (1) BR9806857A (de)
CA (1) CA2277778C (de)
CZ (1) CZ294206B6 (de)
DE (1) DE69825733T2 (de)
FR (1) FR2758143B1 (de)
HU (1) HUP0001458A3 (de)
NZ (1) NZ337087A (de)
WO (1) WO1998030588A1 (de)
ZA (1) ZA9894B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114621336A (zh) * 2020-12-14 2022-06-14 西北农林科技大学 一种酪蛋白源胰脂肪酶抑制肽及其制备方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000226335A (ja) * 1998-12-04 2000-08-15 Amano Pharmaceut Co Ltd 経口用酵素製剤、酵素含有食材及び酵素製剤の服用方法
US6697668B2 (en) 2001-01-25 2004-02-24 Iomed, Inc. Ocular iontophoretic device and method for using the same
FR2824334B1 (fr) * 2001-05-03 2003-10-10 Coletica Procede pour tester une substance eventuellement active dans le domaine de la lipolyse et son utilisation principalement cosmetique
US20040018197A1 (en) * 2002-04-26 2004-01-29 Promega Corporation Treatment for weight loss
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
WO2004090551A2 (en) * 2003-04-08 2004-10-21 Genova, Ltd. Secreted polypeptide species associated with cardiovascular disorders
SE0302253D0 (sv) * 2003-08-21 2003-08-21 Forskarpatent I Syd Ab Lipase-colipase inhibitor
GB0920633D0 (en) 2009-11-25 2010-01-13 Rdbiomed Ltd Inhibition of pancreatic lipase
FR2966734B1 (fr) * 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
US20130144540A1 (en) * 2011-12-06 2013-06-06 Palo Alto Research Center Incorporated Constrained de novo sequencing of peptides
WO2017079299A1 (en) * 2015-11-03 2017-05-11 Mayo Foundation For Medical Education And Research Using colipase inhibitors to treat pancreatitis
EP3651784B1 (de) 2017-07-12 2022-09-28 Mayo Foundation for Medical Education and Research Verbindungen zur verringerung der lipotoxischen beschädigung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248598A (en) * 1989-05-25 1993-09-28 Ivan E. Modrovich Lipase single reagent system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114621336A (zh) * 2020-12-14 2022-06-14 西北农林科技大学 一种酪蛋白源胰脂肪酶抑制肽及其制备方法

Also Published As

Publication number Publication date
CA2277778C (fr) 2013-07-02
FR2758143B1 (fr) 1999-02-19
US6432400B1 (en) 2002-08-13
AU727469B2 (en) 2000-12-14
NZ337087A (en) 2001-01-26
CZ294206B6 (cs) 2004-10-13
ZA9894B (en) 1998-07-08
CN1248264A (zh) 2000-03-22
CZ241499A3 (cs) 2000-01-12
DE69825733T2 (de) 2005-09-01
HUP0001458A2 (hu) 2000-10-28
AU5868698A (en) 1998-08-03
WO1998030588A1 (fr) 1998-07-16
EP0970118A1 (de) 2000-01-12
CA2277778A1 (fr) 1998-07-16
EP0970118B1 (de) 2004-08-18
HUP0001458A3 (en) 2001-04-28
FR2758143A1 (fr) 1998-07-10
DE69825733D1 (de) 2004-09-23
BR9806857A (pt) 2000-03-14

Similar Documents

Publication Publication Date Title
DE69825733D1 (de) Spezifische inhibitoren der pankreatischen lipase und deren anwendungen
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
MXPA05003493A (es) Metodos para generar y seleccionar proteasas con especificidad alterada.
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
DE69831566T2 (de) Probucol monoester zur behandlung von kreislauf- und entzündungserkrankungen
HUP0500560A2 (hu) Mikróbás enzimek új keverékei
WO2004047760A3 (en) Novel chemical compounds
DE60230029D1 (de) Immunisierungstherapie zur behandlung von atherosklerose
ATE419858T1 (de) Krillextrakte zur prävention und/oder behandlung von herz-kreislauf-erkrankungen
DK1043982T3 (da) Lipasehammende polymerer
BR0011838B1 (pt) elemento de sela e estrutura de misturador estático.
ZA99133B (en) Transgenic rabbit that expresses a functional human lipoprotein (A).
ATE555803T1 (de) Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen
TW200504078A (en) Therapeutically active compounds and their use
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
ATE429927T1 (de) Verwendung von lysosomal acid lipase zur behandlung von atherosklerose und ähnlichen krankheiten
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
ATE286119T1 (de) Inhibitoren von cellulolytischen, xylanolytischen und beta-glukanolytischen enzymen
DE69910425D1 (de) Neue therapeutische verwendung von nicergoline
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
ATE213644T1 (de) Kombinationstherapie für die behandlung von arthritis erkrankungen
ATE275949T1 (de) Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria
DE59902857D1 (de) Mittel zur spezifischen hemmung osteoklastärer knochenresorption
DE59813159D1 (de) Kombination der proteolytischen enzyme trypsin, bromelain und papain zur behandlung von glomerulonephritis
WO2003084540A3 (en) Compositions comprising mmp7 modulators for the treatment of chronic pain

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties